June 2026
The U.S. stem cell therapy market size reached USD 6.75 billion in 2025 and is projected to hit around USD 21.31 billion by 2035 with a remarkeble CAGR of 12.18%.
June 2026
The global stem cell therapy for neurological disorders market size was evaluated at USD 2.38 billion in 2025 and is predicted to hit around USD 12.67 billion by 2035, growing at a CAGR of 17.90%.
June 2026
The U.S. cell therapy manufacturing market size was evaluated at USD 1.71 billion in 2025 and is predicted to hit around USD 6.56 billion by 2035, growing at a CAGR of 14.39%.
May 2026
The stem cell therapy market size is expected to increase from USD 18.13 billion in 2025 and it is predicted to hit USD 59.70 billion by 2035 at a CAGR of 12.66%.
December 2025
The global automated and closed cell therapy processing system market size is expected to hit around USD 14.46 billion by 2035 with a CAGR of 22.76%.
November 2025
The global induced pluripotent stem cell (iPSC) therapy market is driven by rising chronic disease prevalence, personalized medicine demand, and advances in regenerative technology.
June 2026
The global engineered TCR (T-Cell Receptor) therapy market is growing as immunotherapies advance for cancer and infectious disease treatment.
June 2026
The global cell and gene therapy quality control and analytics market is expanding with growing demand for robust testing, validation, and compliance in advanced therapies.
June 2026
The global T-cell immunotherapy market size is estimated to hit around USD 29.45 billion by 2035 increasing from USD 8.43 billion in 2025, with a CAGR of 13.33%.
June 2026
The US CAR T-cell therapy market size was evaluated at USD 2,299.97 million in 2025 and is predicted to hit around USD 11,510.04 million by 2035, growing at a CAGR of 17.47%.
June 2026
The global induced pluripotent stem cells market size is estimated to hit around USD 5.57 billion by 2035, increasing from USD 2.13 billion in 2025, with a CAGR of 10.09%.
June 2026
The global cell therapy manufacturing market size was valued at USD 5.55 billion in 2025 and is projected to hit around USD 21.02 billion by 2035 with a CAGR of 14.24%.
June 2026
The U.S. systemic inflammatory response syndrome treatment market size was evaluated at USD 4.88 billion in 2025 and is predicted to hit around USD 8.83 billion by 2035, growing at a CAGR of 6.11%.
June 2026
The U.S. perfusion system market size was evaluated at USD 6,78,407.71 thousand in 2025 and is predicted to hit around USD 16,24,531.09 thousand by 2035, growing at a CAGR of 9.20%.
May 2026
The global automated and closed cell therapy market size is estimated to hit around USD 12.9 billion by 2035 increasing from USD 1.86 billion in 2025, with a CAGR of 21.37%.
May 2026
The global CAR T-cell therapy market size is calculated at USD 5,206.15 million in 2025 and is projected to surpass around USD 26,982.3 million by 2035 with a solid CAGR of 17.88%.
May 2026
The global cell therapy market size is valued at USD 7.43 billion in 2025 and is projected to hit around USD 55.52 billion by 2035 with a CAGR of 22.28%.
May 2026
The global hematopoietic stem cell transplantation market size was evaluated at USD 11.80 billion in 2025 and is predicted to hit around USD 24.32 billion by 2035, growing at a CAGR of 7.50%.
May 2026
The global large-scale active stem cell clinical trials market size was evaluated at USD 7.20 billion in 2025 and is predicted to hit around USD 28.88 billion by 2035, growing at a CAGR of 14.90%.
April 2026
The autologous cell therapy market size was garnered at USD 11.43 billion in 2025 and is expected to hit around USD 60.03 billion by 2035 With a CAGR of 18.04%.
April 2026
The global automation, digitization and robotics in cell and gene therapy manufacturing market size was evaluated at USD 950.00 million in 2025 and is predicted to hit around USD 5,275.10 million by 2035, growing at a CAGR of 18.70%.
April 2026
The global stem cell umbilical cord blood market size was evaluated at USD 18.57 billion in 2025 and is predicted to hit around USD 30.16 billion by 2035, growing at a CAGR of 4.97%.
April 2026
The global cell and gene therapy market size was calculated at USD 8.94 billion in 2025 and is projected to surpass around USD 47.18 billion by 2035 with a solid CAGR of 18.1%.
March 2026
The global synthetic stem cells market size was evaluated at USD 9.10 billion in 2025 and is predicted to hit around USD 75.72 billion by 2035, growing at a CAGR of 23.60%.
February 2026
The global T-cell therapy market size is reached at USD 10.30 billion in 2025 and it is expected to hit around USD 196.21 billion by 2035 with a CAGR of 34.27%.
January 2026
The global stem cells market surpassed USD 18.65 Bn in 2025 and is projected to cross USD 53.32 Bn by 2035, growing at a CAGR of 11.08% from 2026 to 2035.
January 2026
The global image-guided therapy systems market size is projected to hit around USD 11.22 billion by 2035 from USD 6.47 billion in 2025 with a notable CAGR of 5.66%.
January 2026
The global stem cell transplantation market growth is driven by rising cancer cases, advances in regenerative medicine, and increasing stem cell research.
January 2026
The global allogeneic cell therapy devices market size is projected to hit around USD 4,565.79 million by 2035 from USD 511.30 million in 2025 with a CAGR of 24.48%.
December 2025
The U.S. live cell imaging market size is evaluated at USD 900 million in 2025 and is predicted to hit around USD 2,026.67 million by 2035, growing at a CAGR of 8.46%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com